drugset / Trial / NCT00042432

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

NCT00042432

Phase 2 Completed 54 enrolled Amgen
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.

Timeline

Start
2002-06
Primary completion
2003-03
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cinacalcet Other / unclassified 180 mg Oral